Jyrkkä, Johanna https://orcid.org/0000-0003-4929-441X
Paulamäki, Jasmin https://orcid.org/0000-0002-7504-4708
Hartikainen, Sirpa https://orcid.org/0000-0002-4714-455X
Ahonen, Jouni
Antikainen, Riitta https://orcid.org/0000-0001-5262-362X
Jauhonen, Hanna-Mari https://orcid.org/0000-0003-3972-2134
Jämsen, Esa https://orcid.org/0000-0002-8218-7432
Kössi, Anniina https://orcid.org/0009-0008-3302-9009
Laurila, Jouko https://orcid.org/0000-0003-1836-100X
Roitto, Hanna-Maria https://orcid.org/0000-0002-5466-2873
Söderling, Riikka https://orcid.org/0000-0002-5069-5045
Tiihonen, Miia
Huupponen, Risto https://orcid.org/0000-0003-1104-0238
Article History
Accepted: 23 June 2024
First Online: 31 July 2024
Declarations
:
: Open Access funding provided by Finnish Medicines Agency.
: Johanna Jyrkkä, Jasmin Paulamäki, Sirpa Hartikainen, Jouni Ahonen, Riitta Antikainen, Hanna-Mari Jauhonen, Esa Jämsen, Anniina Kössi, Jouko Laurila, Hanna-Maria Roitto, Riikka Söderling, Miia Tiihonen and Risto Huupponen have no conflicts of interest that are directly relevant to the content of this article. All authors are or have been the members of the Meds75+ expert panel.
: Not applicable.
: Not applicable.
: Not applicable.
: The content of Meds75+ is available as open data via Fimea’s website (). Content is integrated into FimeaWeb (). The National indicator reporting Class D medicine use is available via THL’s website, indicator 5036 ().
: Not applicable.
: Concept and design: all authors. Conception and design: all authors. Acquisition, analysis or interpretation of data: all authors. Data analysis: J.J. and J.P. Drafting of the manuscript: J.J., J.P., S.H., H.J., A.K. and R.H. Critical revision of the manuscript for important intellectual content: all authors. All authors approved the final version of the manuscript.
: Abstract concerning this review article was published (Eur Geriatr Med 2023;14(Suppl 1):348) as part of the academic meeting of Eu-GMS congress on 20–22 September 2023 (word count 258).